Cardiac Biomarkers Market Projected to Reach USD 4,957.1 million by 2025 – Roche, Abbott, Siemens, Alere, Becton, Bio-Rad, BioMerieux, Randox, Beckman Coulter, Thermo Fisher

Press Release

Sameer Joshi                                
Call: +912067274191
Email: [email protected]
Pune, Feb 19,2020

Global cardiac biomarkers market is valued at approximately USD 1,241 million in 2017 and is anticipated to grow with a healthy growth rate of more than 18.9 % over the forecast period 2018-2025. Rising prevalence of cardiovascular diseases cost effective device, non-invasive method, accuracy in prediction, helpful in clinical trials, multi-application, increasing point of care application along with the technological advancements using cardiac biomarkers are some key trends that are responsible for the wide adoption of cardiac biomarkers globally.

On the basis of segmentation, the cardiac biomarkers market is segmented into type, application and location of testing. The type segment of global Cardiac Biomarkers market is classified into creatine Kinase (CK-MB), Troponins (T.I), myoglobin, Natriuretic Peptides (BNP & NT-PROBNP), ischemia modified albumin, others. Based on application segment the global cardiac biomarkers market is classified into myocardial infarction, congestive heart failure, acute coronary syndrome, Atherosclerosis, other applications of which myocardial infarction holds the highest share in the global cardiac biomarkers market due to high prevalence of cardiovascular diseases. The location of testing segment includes point of care testing and laboratory testing of which point of care accounts for the fastest growing segment due to clinicians and doctors mainly use point of care cardiac testing for quick testing and monitoring patients who are having chest pain.

Get Sample PDF For More Professional And Technical Insights at: https://www.premiummarketinsights.com/sample/BRC00018262

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
– Myocardial muscle Creatine Kinase (CK-MB)
– Myoglobin
– Troponins (T and I)
– Ischemia Modified Albumin (IMA)
– Brain Natriuretic Peptide (BNPs) or NT-proBNP
– Others
By Application:
– Congestive Heart Failure
– Myocardial Infarction
– Atherosclerosis
– Acute Coronary Syndrome
– Others
By Location of testing:
– Laboratory testing
– Point of care testing
By Regions:
– North America
o U.S.
o Canada
– Europe
o UK
o Germany
o ROE
– Asia Pacific
o China
o India
o Japan
o ROAPEC
– LAMEA
o Brazil
o Mexico
– ROW
o Middle East & Africa

Purchase Complete Report at: https://www.premiummarketinsights.com/buy/BRC00018262

Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider.